Synairgen Share Discussion Threads

[tickboo] 24/3/2020 12:38

Fair play re DEMG. Can't buy £150 (10,000) at fixed price but can sell 100,000 at 1.45p. Will move even more quickly with more volume although MMs putting people off with NT.

[jev1] 24/3/2020 12:02

Hazl

Agree. By a very long way.

[davew28] 24/3/2020 12:01

Sure I saw a figure quoted yesterday in I think a Times newsaper comment saying that COPD was the second worst condition for COVID-19 suffers in NHS England but I can't seem to find any stats breakdown to validate that, although it is probably credible. If that was the case I guess all COPD and Asthma suffers would probably see the inhaler as a potential life saver, should the trial have a positive outcome.

[hazl] 24/3/2020 11:57

This is the best currently in my opinion.

[tickboo] 24/3/2020 11:56

Yep trying to get 100,000 in DEMG too although NT so will wait for a quote.

[nobbygnome] 24/3/2020 11:46

Yes it has not been a good investment overall but like all stocks has gone down too far. Their kit is in ICUs so will be being used more. Look at what happened to LID yesterday. Both products are involved in fluid management....

[hazl] 24/3/2020 11:46

'Interferon beta

The UK biotech firm Synairgen has been given fast-track approval to trial a lung-disease drug in Covid-19 sufferers. The compound, interferon beta, forms part of the lung’s natural defence system against viruses and was originally developed for patients with chronic obstructive pulmonary disorder, or COPD. The hope is that administering interferon beta boosts the body’s ability to fight the virus, especially in those who have weakened immune systems. It was identified in February by the WHO as the only therapy in phase-2 trials that can be inhaled, meaning patients can administer it themselves through a small battery-operated nebuliser.'
The guardian

[hazl] 24/3/2020 11:43

Nobby I see you started the thread,years ago of the one you posted above....what price did you get in at?
Looks a bit risky?

[hazl] 24/3/2020 11:41

for anybody new

[saw89] 24/3/2020 11:14

Gotta say there will be some regretful sellers . SNG = Biggest no brainer buy and hold on the market atm.

[nobbygnome] 24/3/2020 11:06

Wouldn't normally do this but DEMG about to take off IMHO. Their kit is used in ICUs similar to LID which went mad yesterday.

DYOR...

[talk2dubya] 24/3/2020 10:59

Premium on ask now. I agree if the initial two weeks dosing proves to be positive they will seek to accelerate - just need the Donald in charge.

[saw89] 24/3/2020 10:59

Hello, wake up market. FARN Mcap 5 times higher. SNG is a superior delivery method, being trialled in the NHS now, is on the radar of the WHO and now we know has Astra Zeneca involved.

[saw89] 24/3/2020 10:42

Any whiff of this helping patients in critical condition and this could be the stock everyone remembers for years to come

[nobbygnome] 24/3/2020 10:39

Traders is the simple answer, of which sometimes I am one. However, the big money here is going to be made holding on as the price rises during the trial period and then of course if the result is positive. I am sure all sensible investors will take a little off the table before the results but that is most definitely not a consideration now. The beauty here is we have a very defined timeframe.

[toffeeman] 24/3/2020 10:36

It's called supply and demand iamgreat1

[iamgreat1] 24/3/2020 10:34

How is this still under 50p

[nobbygnome] 24/3/2020 10:29

>> tidy

It would be a lot more than £270 million for this indication especially if other indications were included as well...

[nobbygnome] 24/3/2020 10:28

>> saw

Precisely. There is no way SNG could market the drug themselves and they need a partner. The more I think about it, the more a tie up in the very short term is inevitable. Needless to say that would send the price stratospheric because the risk for SNG would be reduced albeit the ultimate return also reduced. However, as I say it is inevitable because they can't do it themselves.

[tidy 2] 24/3/2020 10:27

Exactly. I wonder, is it a case of being swamped under by the COVID19 crisis or could we get duel RNS for COPD and COVID19 tie up with AZN. Obviously very busy. So if the collaboration which ended in 2017 is now back on with AZN which was for 230m? Are we back to this funding point from AZN.

[74tom] 24/3/2020 10:26

The link to the research article referenced in the AZN piece;



“Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies”

[saw89] 24/3/2020 10:26

Beautiful thing about Astra Zeneca being on the scene is they have all the manufacturing, logistics and distribution already in place to get this rolled out rapidly

[nobbygnome] 24/3/2020 10:23

Just thinking about it, that is a highly relevant bit of information and significantly increases the chance of a tie up with AZ. If nothing else, that should get people to start buying again. Of course no guarantee of a tie up but the chances have just gone up.

[saw89] 24/3/2020 10:22

Quite clearly high probability of an unexpected wild card RNS regarding additional Astra Zeneca involvement.